Sino Biopharmaceutical (1177.HK) - EPS (earnings per share)

EPS in 2021 (TTM): NZ$0.05267

According to Sino Biopharmaceutical's latest financial reports the company's current EPS (TTM) is NZ$0.06186. In 2023 the company made an earnings per share (EPS) of NZ$0.03084 a decrease over its 2022 EPS that were of NZ$0.03415.

EPS history for Sino Biopharmaceutical from 1999 to 2021

Annual EPS

Year	EPS	Change
2023	NZ$0.03084	-9.68%
2022	NZ$0.03415	-83.86%
2021	NZ$0.21	440.46%
2020	NZ$0.03914	7.54%
2019	NZ$0.03639	-70.37%
2018	NZ$0.12	254.37%
2017	NZ$0.03466	41.55%
2016	NZ$0.02448	2.59%
2015	NZ$0.02387	17.63%
2014	NZ$0.02029	45.97%
2013	NZ$0.01390	16.34%
2012	NZ$0.01195	93.4%
2011	NZ$0.006178	-20.02%
2010	NZ$0.007724	33.16%
2009	NZ$0.005800	774.72%
2008	NZ$0.0006631	-79.69%
2007	NZ$0.003265	58.8%
2006	NZ$0.002056	-91.05%
2005	NZ$0.02297	723.97%
2004	NZ$0.002787	105.48%
2003	NZ$0.001357	-67.27%
2002	NZ$0.004145	-8.26%
2001	NZ$0.004518	17.18%
2000	NZ$0.003855	0.14%
1999	NZ$0.003850

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Sino Biopharmaceutical (1177.HK)